158 related articles for article (PubMed ID: 21934653)
1. Co-operative membrane disruption between cell-penetrating peptide and cargo: implications for the therapeutic use of the Bcl-2 converter peptide D-NuBCP-9-r8.
Watkins CL; Sayers EJ; Allender C; Barrow D; Fegan C; Brennan P; Jones AT
Mol Ther; 2011 Dec; 19(12):2124-32. PubMed ID: 21934653
[TBL] [Abstract][Full Text] [Related]
2. Intracellular delivery of peptide cargos using iron oxide based nanoparticles: studies on antitumor efficacy of a BCL-2 converting peptide, NuBCP-9.
Kumar M; Singh G; Sharma S; Gupta D; Bansal V; Arora V; Bhat M; Srivastava SK; Sapra S; Kharbanda S; Dinda AK; Singh H
Nanoscale; 2014 Nov; 6(23):14473-83. PubMed ID: 25340469
[TBL] [Abstract][Full Text] [Related]
3. Investigation of Intracellular Delivery of NuBCP-9 by Conjugation with Oligoarginines Peptides in MDA-MB-231 Cells.
Wang W; Suga T; Hagimori M; Kuroda N; Fuchigami Y; Kawakami S
Biol Pharm Bull; 2018; 41(9):1448-1455. PubMed ID: 30175779
[TBL] [Abstract][Full Text] [Related]
4. Novel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9.
Kumar M; Gupta D; Singh G; Sharma S; Bhat M; Prashant CK; Dinda AK; Kharbanda S; Kufe D; Singh H
Cancer Res; 2014 Jun; 74(12):3271-81. PubMed ID: 24741005
[TBL] [Abstract][Full Text] [Related]
5. Curvature engineering: positive membrane curvature induced by epsin N-terminal peptide boosts internalization of octaarginine.
Pujals S; Miyamae H; Afonin S; Murayama T; Hirose H; Nakase I; Taniuchi K; Umeda M; Sakamoto K; Ulrich AS; Futaki S
ACS Chem Biol; 2013 Sep; 8(9):1894-9. PubMed ID: 23834464
[TBL] [Abstract][Full Text] [Related]
6. Combination of mitochondria targeting doxorubicin with Bcl-2 function-converting peptide NuBCP-9 for synergistic breast cancer metastasis inhibition.
Yang J; Li Q; Zhou R; Zhou M; Lin X; Xiang Y; Xie D; Huang Y; Zhou Z
J Mater Chem B; 2021 Feb; 9(5):1336-1350. PubMed ID: 33443508
[TBL] [Abstract][Full Text] [Related]
7. Noncovalent Strategy with Cell-Penetrating Peptides to Facilitate the Brain Delivery of Insulin through the Blood-Brain Barrier.
Kamei N; Yamaoka A; Fukuyama Y; Itokazu R; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(4):546-554. PubMed ID: 29607927
[TBL] [Abstract][Full Text] [Related]
8. Gold Cluster Capped with a BCL-2 Antagonistic Peptide Exerts Synergistic Antitumor Activity in Chronic Lymphocytic Leukemia Cells.
Yao Y; Lu C; Gao L; Cao K; Yuan H; Zhang X; Gao X; Yuan Q
ACS Appl Mater Interfaces; 2021 May; 13(18):21108-21118. PubMed ID: 33942607
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.
Kamei N; Onuki Y; Takayama K; Takeda-Morishita M
J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728
[TBL] [Abstract][Full Text] [Related]
10. Dipicolylamine/Metal Complexes that Promote Direct Cell-Membrane Penetration of Octaarginine.
Kawaguchi Y; Ise S; Azuma Y; Takeuchi T; Kawano K; Le TK; Ohkanda J; Futaki S
Bioconjug Chem; 2019 Feb; 30(2):454-460. PubMed ID: 30428256
[TBL] [Abstract][Full Text] [Related]
11. Induction of Ca²+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction.
Zhong F; Harr MW; Bultynck G; Monaco G; Parys JB; De Smedt H; Rong YP; Molitoris JK; Lam M; Ryder C; Matsuyama S; Distelhorst CW
Blood; 2011 Mar; 117(10):2924-34. PubMed ID: 21193695
[TBL] [Abstract][Full Text] [Related]
12. A short Nur77-derived peptide converts Bcl-2 from a protector to a killer.
Kolluri SK; Zhu X; Zhou X; Lin B; Chen Y; Sun K; Tian X; Town J; Cao X; Lin F; Zhai D; Kitada S; Luciano F; O'Donnell E; Cao Y; He F; Lin J; Reed JC; Satterthwait AC; Zhang XK
Cancer Cell; 2008 Oct; 14(4):285-98. PubMed ID: 18835031
[TBL] [Abstract][Full Text] [Related]
13. Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis.
Tumilasci VF; Olière S; Nguyên TL; Shamy A; Bell J; Hiscott J
J Virol; 2008 Sep; 82(17):8487-99. PubMed ID: 18579592
[TBL] [Abstract][Full Text] [Related]
14. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
15. A TR3/Nur77 peptide-based high-throughput fluorescence polarization screen for small molecule Bcl-B inhibitors.
Yip KW; Godoi PH; Zhai D; Garcia X; Cellitti JF; Cuddy M; Gerlic M; Chen Y; Satterthwait A; Vasile S; Sergienko E; Reed JC
J Biomol Screen; 2008 Aug; 13(7):665-73. PubMed ID: 18626112
[TBL] [Abstract][Full Text] [Related]
16. Cell-penetrating peptides induce apoptosis and necrosis through specific mechanism and cause impairment of Na
Qiu Y; Yu Q; Shi K; Zhang M; Zhou X; Yang Y; Liu Y; Tang J; Wang X; He Q
Amino Acids; 2017 Jan; 49(1):75-88. PubMed ID: 27645217
[TBL] [Abstract][Full Text] [Related]
17. Effects of pyrenebutyrate on the translocation of arginine-rich cell-penetrating peptides through artificial membranes: recruiting peptides to the membranes, dissipating liquid-ordered phases, and inducing curvature.
Katayama S; Nakase I; Yano Y; Murayama T; Nakata Y; Matsuzaki K; Futaki S
Biochim Biophys Acta; 2013 Sep; 1828(9):2134-42. PubMed ID: 23711826
[TBL] [Abstract][Full Text] [Related]
18. Cooperative Cellular Uptake and Activity of Octaarginine Antisense Peptide Nucleic acid (PNA) Conjugates.
Ghavami M; Shiraishi T; Nielsen PE
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31581514
[TBL] [Abstract][Full Text] [Related]
19. Intracellular Bacterial Targeting by a Thiazolyl Benzenesulfonamide and Octaarginine Peptide Complex.
Ratrey P; Datta B; Mishra A
ACS Appl Bio Mater; 2022 Jul; 5(7):3257-3268. PubMed ID: 35736131
[TBL] [Abstract][Full Text] [Related]
20. Coated microneedles mediated intradermal delivery of octaarginine/BRAF siRNA nanocomplexes for anti-melanoma treatment.
Ruan W; Zhai Y; Yu K; Wu C; Xu Y
Int J Pharm; 2018 Dec; 553(1-2):298-309. PubMed ID: 30347273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
